Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE)
- Takuya Higashiyama
- , Kiminori Sugino
- , Hisato Hara
- , Ken ichi Ito
- , Noriaki Nakashima
- , Naoyoshi Onoda
- , Masayuki Tori
- , Hiroshi Katoh
- , Naomi Kiyota
- , Ichiro Ota
- , Nobuyasu Suganuma
- , Yatsuka Hibi
- , Toshimitsu Nemoto
- , Shunji Takahashi
- , Katsunari Yane
- , Tetsuya Ioji
- , Shinsuke Kojima
- , Hideaki Kaneda
- , Iwao Sugitani
- , Makoto Tahara
Research output: Contribution to journal › Article › peer-review
40
Link opens in a new tab
Citations
(Scopus)